SCHEMBL8042540

SCHEMBL8042540

O=[N+]([O-])c1ccc(OS(=O)(=O)c2ccccc2I)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 4/20 0.53
CA9 Q16790 4/20 0.53
CA1 P00915 3/20 0.53
HTT P42858 1/20 0.52
ALDH1A1 P00352 3/20 0.46
HSP90AA1 P07900 1/20 0.46
MAPT P10636 4/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
LMNA P02545 3/20 0.44
POLB P06746 1/20 0.44
HPGD P15428 3/20 0.44
GAA P10253 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
MAPK1 P28482 1/20 0.43
CA12 O43570 3/20 0.42
ALPL P05186 1/20 0.41
ALPI P09923 1/20 0.41
RAB9A P51151 1/20 0.41
HSPB1 P04792 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18045522 0.82 POLB (0.55) CA2CA9CA1HTTALDH1A1
SCHEMBL10936546 0.80 CA1 (0.47) CA2CA9CA1ALDH1A1MEN1
SCHEMBL28277668 0.78 MAPT (0.52) CA2CA9CA1HTTALDH1A1
Iodobenzene SCHEMBL2901136 0.78 HTT (0.46) CA2CA9CA1HTTALDH1A1
Iodobenzene SCHEMBL2904039 0.78 MEN1 (0.55) CA2CA9CA1HTTALDH1A1
SCHEMBL14594621 0.78 HTT (0.62) CA2CA9CA1HTTALDH1A1
SCHEMBL28743859 0.78 PPARG (0.47) CA2CA9CA1HTTALDH1A1
SCHEMBL28746185 0.78 TDP1 (0.59) CA2CA9CA1ALDH1A1MAPT
SCHEMBL28087812 0.76 HTT (0.60) CA2CA9CA1HTTALDH1A1
SCHEMBL11041999 0.76 HTT (0.59) CA2CA9CA1HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6083951-A FOR THE TREATMENT OF DISEASES OR MEDICAL CONDITIONS SUCH AS HYPERTENSION, PULMONARY HYPERTENSION, CARDIAC OR CEREBRAL CIRCULATORY DISEASE AND RENAL DISEASE ZENECA LIMITED (GB) 2000-07-04 US disclosed
EP-0752986-B1 N-HETEROCYCLYL SULPHONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LTD (GB) 1999-05-19 EP disclosed
US-5861401-A TREATMENT OF CONGESTIVE HEART FAILURE ZENECA LIMITED (GB) 1999-01-19 US disclosed
EP-0752986-A1 N-HETEROCYCLYL SULPHONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LIMITED (GB) 1997-01-15 EP disclosed
WO-1995026957-A1 N-HETEROCYCLYL SULPHONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LIMITED (GB) 1995-10-12 WO disclosed